News | January 24, 2025
             
           Alivus Life Sciences delivers 12% revenue growth
EBITDA margins expand to 31.3%
EBITDA margins expand to 31.3%
Morepen Laboratories approves hiving off of medical devices business
 
        Subscribe To Our Newsletter & Stay Updated